NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Nuclear factor κ-B (NFκB) is activated in iPSC-cardiac myocytes from patients with arrhythmogenic cardiomyopathy (ACM) under basal conditions, and inhibition of NFκB signaling prevents disease in Dsg2 mut/mut mice, a robust mouse model of ACM. Here, we used genetic approaches and single-cell RNA-Seq to define the contributions of immune signaling in cardiac myocytes and macrophages in the natural progression of ACM using Dsg2 mut/mut mice. We found that NFκB signaling in cardiac myocytes drives myocardial injury, contractile dysfunction, and arrhythmias in Dsg2 mut/mut mice. NFκB signaling in cardiac myocytes mobilizes macrophages expressing C-C motif chemokine receptor-2 (CCR2 + cells) to affected areas within the heart, where they mediate myocardial injury and arrhythmias. Contractile dysfunction in Dsg2 mut/mut mice is caused both by loss of heart muscle and negative inotropic effects of inflammation in viable muscle. Single nucleus RNA-Seq and cellular indexing of transcriptomes and epitomes (CITE-Seq) studies revealed marked proinflammatory changes in gene expression and the cellular landscape in hearts of Dsg2 mut/mut mice involving cardiac myocytes, fibroblasts, and CCR2 + macrophages. Changes in gene expression in cardiac myocytes and fibroblasts in Dsg2 mut/mut mice were dependent on CCR2 + macrophage recruitment to the heart. These results highlight complex mechanisms of immune injury and regulatory crosstalk between cardiac myocytes, inflammatory cells, and fibroblasts in the pathogenesis of ACM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recent works have demonstrated CCR2+ macrophages are early and persistent drivers of cardiac inflammation in ACM [12].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The germline Dsg2mut/mut mouse model developed by Chelko SP and colleagues represents a more genetically relevant system for studying ACM pathogenesis, as the Dsg2 mutation is germline, mirroring the pattern of inheritance observed in patients [12,60].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Direct pharmacologic inhibition of the master regulator of inflammatory signaling, NFκB, via the small molecule Bay 11-7082, normalized myocardial levels of several pro-inflammatory cytokines (e.g., IL-1β, IFN-γ, and IL-12), chemokines (e.g., LIX and CCL2), and fibrokines (e.g., OPN and POSTN) with ameliorated myocardial injury and improvement in cardiac function [12].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further analyses identified expansion of inflammatory macrophage subsets interacting with activated fibroblast populations, forming inflammatory–fibrotic niches that promote cardiac remodeling [12].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multi-omic analyses, including single-nucleus RNA sequencing (snRNAseq) and cellular indexing of transcriptomes and epitopes sequencing (CITE-Seq), demonstrated inflammatory transcriptional reprogramming across cardiomyocytes, fibroblasts, and both myeloid and lymphoid lineage cells, indicating extensive immune–stromal crosstalk during disease progression [12].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq025 · Cited by 1,612
Self-citationRight Ventricular Dysplasia: A Report of 24 Adult Cases
Marcus, F. I., Fontaine, G. H., Guiraudon, G., Frank, R., Laurenceau, J. L., Malergue, C., & Grosgogeat, Y. (1982) · Circulation · doi:10.1161/01.cir.65.2.384 · Cited by 1,603
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Traenckner, E. B., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S., & Baeuerle, P. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07287.x · Cited by 1,013 · cited 2×
“NFĸB signaling drives myocardial injury via CCR2 + macrophages in a preclinical model of arrhythmogenic cardiomyopathy a I κ B αΔ N isoform that is nonphosphorylatable at Ser32/36 and, thus, retains inactivated-NFĸB within the cytoplasm of cardiac myocytes (15, 16).”
Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00332-x · Cited by 978 · cited 4×
“Inflammation in ACM has usually been considered in the context of inflammatory cell infiltrates in the heart, which occur frequently and can be extensive (3–5).”
InfluentialCoghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00025-9 · Cited by 897 · cited 1×
“Bay 11-7082, a small molecule that inhibits NF κ B signaling by blocking degradation of the inhibitor of κ-B-α ( I κ B α) (9), arrests disease expression and prevents myocardial injury, contractile dysfunction, and ECG abnormalities in Dsg2 mut/mut mice (6).”
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 1×
“These data are consistent with a known role of Postn + fibroblasts in fibrosis-associated myocardial infarction and pressure overload (29, 32, 33).”
The mechanism of HMGB1 secretion and release
Chen, R., Kang, R., & Tang, D. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00736-w · Cited by 849
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762 · cited 1×
“HMGB1 is a nonhistone DNA-binding protein that is associated with necrotic forms of cell death (20); it acts as a damage-associated molecular pattern (DAMP) and initiates local inflammation via activation of macrophages and neutrophils (21).”
Cited by
Functional diversity of cardiac macrophages in health and disease
Yang, S. H., Penna, V. R., & Lavine, K. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01109-8 · Cited by 73
Self-citationCardiac fibroblasts in myocardial injury and heart failure
Linthout, S. V., Matz, I., González, A., & Davis, J. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf902 · Cited by 47
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies
Bassetto, G., Angriman, F., Gava, C. P. L. D., Paldino, A., Perotto, M., Bordignon, L., Gigli, M., Ferro, M. D., Massa, L., Altinier, A., et al. (2025) · Current Cardiology Reports · doi:10.1007/s11886-024-02168-6 · Cited by 41
Interleukin-1β Drives Disease Progression in Arrhythmogenic Cardiomyopathy
Penna, V. R., Amrute, J., Engel, M., Shiel, E. A., Farra, W., Cannon, E. N., Leu-Turner, C., Ma, P., Villanueva, A., Shin, H.-W., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101542 · Cited by 15
Self-citationPeretto, G., Villatore, A., & Cooper, L. T. (2026) · Immunological Reviews · doi:10.1111/imr.70105 · Cited by 10
Soussi, S., Maione, A. S., Lefèvre, L., Pizzinat, N., Iacovoni, J. S., Gonzalez-Fuentes, I., Cussac, D., Iengo, L., Santin, Y., Tundo, F., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07364-y · Cited by 11
The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Psarras, S. (2024) · Biomolecules · doi:10.3390/biom14111403 · Cited by 9
Aging and sinus node dysfunction: mechanisms and future directions
Mesquita, T., Miguel‐dos‐Santos, R., & Cingolani, E. (2025) · Clinical Science · doi:10.1042/cs20231025 · Cited by 10
Centner, A. M., Shiel, E. A., Farra, W., Cannon, E. N., Landim-Vieira, M., Salazar, G., & Chelko, S. P. (2024) · Nutrients · doi:10.3390/nu16132087 · Cited by 8
Self-citationTargeting arrhythmogenic macrophages: lessons learned from arrhythmogenic cardiomyopathy
Mesquita, T., & Cingolani, E. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180482 · Cited by 8
Zheng, X. X., Wang, J., Chen, W., Xu, Q., Xu, T., & Chen, L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332026 · Cited by 7
Single-Cell RNA Sequencing and Combinatorial Approaches for Understanding Heart Biology and Disease
Wang, L., & Jin, B. (2024) · Biology · doi:10.3390/biology13100783 · Cited by 9
Ostini, A., Kléber, A. G., Rudy, Y., Saffitz, J. E., & Kučera, J. (2025) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.124.013658 · Cited by 6
Self-citationLow, B. S. H., & Asimaki, A. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10567-x · Cited by 7
Role of macrophages in cardiac arrhythmias: Pathogenesis and therapeutic perspectives
Yang, Y., Fan, A., Lin, H., Wang, X., Yang, K., Zhang, H., Fan, G., & Li, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114206 · Cited by 6
Shiel, E. A., Farra, W., Medarev, S. L., Ariyaratne, G. H. D. N., Cannon, E. N., Steiner, J. L., & Chelko, S. P. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00416.2025 · Cited by 5
Self-citationTissue‐Resident Memory T Cells in the Heart: An Emerging Role in Chronic Inflammation
Manandhar, P., Yan, A., & Moslehi, J. J. (2026) · Immunological Reviews · doi:10.1111/imr.70134 · Cited by 3
Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy
Cui, H., Shu, S., Zhang, N., Wang, M., Yang, T., Wang, Z., Chen, X., Fu, M., Xu, M., Yang, Y., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04024-y · Cited by 3
A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease
Ariyaratne, G. H. D. N., Villatore, A., Peretto, G., & Chelko, S. P. (2026) · Cells · doi:10.3390/cells15100868 · Cited by 2
Self-citation(2026) · doi:10.1161/jaha.125.047447 · Cited by 2
Dysfunctional cardiomyocyte signalling and heart disease
Ridgway, Z., & Li, X. (2025) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2025.102517 · Cited by 1
Han, D. D., Brooks, A. C., Baker, C. D., Dirkx, R. A., Mickelsen, D. M., Fisler, B., Phadke, K., Ashton, J. M., Delmar, M., & Small, E. M. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013966 · Cited by 1
Вайханская, Т. Г. (2025) · Кардиология в Беларуси · doi:10.34883/pi.2025.17.6.008 · Cited by 1
Impact of 18 FDG-Avidity and Immunosuppression on Idiopathic and Genetic Cardiomyopathies
Tabaghi, S., Bevan, G. H., Hankinson, S. E., Gumuser, E. D., Lal, M., Pico, M. G., Chatterjee, N. A., Vasbinder, A. L., Cheng, R. K.-H., Stempien‐Otero, A., et al. (2026) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.126.019970 · Cited by 1
Azeez, T. A., Pierre, C. J., Ihrig, C. M., Chelko, S. P., Muller‐Delp, J. M., & Favor, J. D. L. (2025) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00133.2025 · Cited by 1
Self-citationCirnu, A., Williams, T., Noerpel, M., Kammerer, J., Kannt, S., Heil, M., Kimmel, L., Arias-Loza, P.-A., Lhoda, M., Hennig, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.11.693827 · Cited by 1
Prognostic Value of Circulating Biomarkers of Fibrotic Remodeling in Arrhythmogenic Cardiomyopathy
Chelko, S. P. (2024) · Biomedicines · doi:10.3390/biomedicines12112623
Self-citationHanns, P., Colpaert, R. M. W., Castellanos-Martínez, R., Weidner, F., Beensen, S., Matthias, F., Xu, L., Kuster, G. M., & Schinner, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.23.643549
Landim-Vieira, M., Jani, V., Shiel, E., Rastegarpouyani, H., Engel, M., Cullup, F. P., Chastain, R., Farra, W., Ma, W., Toepfer, C. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680335
Self-citationLavine, K. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13279-7.00033-x
Self-citationQiu, H., & Gladysheva, I. P. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm48589
Pathak, S., Stangner, K., Kempf, E., Moztarzadeh, S., Hiermaier, M., Wider, S., Rauschmayer, M., Williams, T., Stengl, A., Gerull, B., et al. (2026) · Acta Physiologica · doi:10.1111/apha.70254
Li, M., Meng, L.-B., & 陈作观 (2026) · Research Square · doi:10.21203/rs.3.rs-9574902/v1
Prioritizing Discovery and Advancements in Arrhythmia Therapies
Hanna, P., Boyle, P. M., Caldwell, J. L., Refaey, M. E., Goodyer, W. R., Khurshid, S. S., Mesubi, O. O., Palatinus, J. A., Pfenniger, A., Ajijola, O. A., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.05.005
Self-citationMinor, K., Lee, C. F., & Nizami, H. L. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00633.2026
Inflammatory Hot Phases in Arrhythmogenic Cardiomyopathy
Zarghami, M., Maleki, N. D., Naddaf, S., Abdulhadi, T., Grabos, M., Kanan, A., Osser, D., Mahdavinia, A., Gulati, S., & Singh, A. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103154
The role of inflammation in arrythmogenic cardiomyopathy
Κουτσούκης, Α. Σ. (2026) · University of Thessaly Institutional Repository (University of Thessaly)
Che, L., & Wang, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1896304
Villatore, A., Trezza, A. F., Biondi, F., Valentino, F., Palmisano, A., Guicciardi, N. A., Benzoni, G., Ascione, G., Resta, C. D., Esposito, A., et al. (2026) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2026.08.004
CD14 Blockade Attenuates Arrhythmogenic CardiomyopathyPreprint
Penna, V. R., Shiel, E. A., Farra, W., Cannon, E. N., Landim-Vieira, M., Owen, M. C., Venkatesan, R., Heo, G. S., Das, A., Liu, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.30.755828
Self-citation
Metadata
- Authors
- Chelko, S. P., Penna, V. R., Engel, M., Shiel, E. A., Centner, A. M., Farra, W., Cannon, E. N., Landim-Vieira, M., Schaible, N., Lavine, K., & Saffitz, J. E.
- Affiliations
- Florida State University (US)
- Washington University in St. Louis (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Chelko, Stephen P.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2024-04-02
- Volume
- 134
- Issue
- 10
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC11093597
- OpenAlex
- W4393549560
- Cited by
- 32
- References
- 43
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 6
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (R01-HL148348, P30AR073752, R35 HL161185, 5T32AI007163-44)
- American Heart Association (19CDA34760185)
- Fondation Leducq (#20CVD02)
- Burroughs Wellcome Fund (1014782)
- Children’s Discovery Institute (CH-II-2015-462,CH-II-2017-628)
- St. Louis Children’s Hospital (PM-LI-2019-829)
- Foundation of Barnes-Jewish Hospital (8038-88)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- arrhythmogenic cardiomyopathy, NF-κB signaling, CCR2+ macrophages, myocardial injury, cardiomyocytes, macrophage recruitment, cardiac arrhythmias, contractile dysfunction, cardiac fibroblasts, inflammation, single-cell RNA sequencing, CITE-seq
- MeSH terms
- Animals, Disease Models, Animal, Humans, Macrophages, Myocardium, Signal Transduction, NF-kappa B, Arrhythmogenic Right Ventricular Dysplasia, Myocytes, Cardiac, Desmoglein 2, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.